dr. Ariel Pradipta, M.Res., Ph.D.

dr. Ariel Pradipta, M.Res., Ph.D.

Teaching Staff at the Department of Biochemistry and Molecular Biology, FMUI

Biography

dr. Ariel Pradipta, M.Res., Ph.D. serves as a member of the teaching staff at the Department of Biochemistry and Molecular Biology, FMUI, alongside his role as Chief Scientific Officer at GSI Lab. With extensive international postdoctoral training in immunopathology, his professional expertise lies at the intersection of host immunobiology, genomic epidemiology, and cutting-edge Next-Generation Sequencing (NGS) platform technologies. He actively coordinates key health initiative projects focusing on active aging and longevity.

Education

  • Ph.D. in Biomedical Science (Host Immunology), Faculty of Medicine, Osaka University, Japan
  • M.Res. in Immunobiology, Faculty of Medicine, Newcastle University upon Tyne, United Kingdom
  • Medical Doctor (dr. / S-1), Faculty of Medicine, Universitas Indonesia

Publications

  • Bando H, Pradipta A, Iwanaga S, Yamamoto M, Sasai M, Ma JS, Okamoto M. Cell-autonomous Toxoplasma killing program requires Irgm2 but not its microbe vacuolar localization. Journal of Experimental Medicine (JEM).
  • Pradipta A, et al. Characteristics and clinical outcomes of patients with pre-delta, delta and omicron SARS-CoV-2 infection in Indonesia (2020–2023): a multicentre prospective cohort study.
  • Nuriah C, Iswanti FC, Pradipta A. The Role of High Sensitivity C-Reactive Protein as an Inflammation Predictor in Cardiovascular Diseases. Bioscientia Medicina: Journal of Biomedicine and Translational Research. 2024.